Literature DB >> 21948470

Imaging luciferase-expressing viruses.

Michael A Barry1, Shannon May, Eric A Weaver.   

Abstract

Optical imaging of luciferage gene expression has become a powerful tool to track cells and viruses in vivo in small animal models. Luciferase imaging has been used to study the location of infection by replication-defective and replication-competent viruses and to track changes in the distribution of viruses in mouse models. This approach has also been used in oncolytic studies as a noninvasive means to monitor the growth and killing of tumor cells modified with luciferase genes. In this chapter, we describe the techniques used for luciferase imaging as have been applied to track replication-defective and replication-competent adenoviruses in mouse and hamster models of oncolysis and virus pharmacology. Although these methods are simple, the process of obtaining accurate luciferase imaging data has many caveats that are discussed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21948470      PMCID: PMC4123112          DOI: 10.1007/978-1-61779-340-0_6

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  11 in total

1.  Targeting adenoviruses with factor x-single-chain antibody fusion proteins.

Authors:  Christopher Y Chen; Shannon M May; Michael A Barry
Journal:  Hum Gene Ther       Date:  2010-06       Impact factor: 5.695

2.  Evaluation of polyethylene glycol modification of first-generation and helper-dependent adenoviral vectors to reduce innate immune responses.

Authors:  Hoyin Mok; Donna J Palmer; Philip Ng; Michael A Barry
Journal:  Mol Ther       Date:  2005-01       Impact factor: 11.454

3.  Polyethylene glycol modification of adenovirus reduces platelet activation, endothelial cell activation, and thrombocytopenia.

Authors:  Sean E Hofherr; Hoyin Mok; Francisca C Gushiken; Jose A Lopez; Michael A Barry
Journal:  Hum Gene Ther       Date:  2007-09       Impact factor: 5.695

4.  Development and characterization of enhanced green fluorescent protein and luciferase expressing cell line for non-destructive evaluation of tissue engineering constructs.

Authors:  Jeremy S Blum; Johnna S Temenoff; Hansoo Park; John A Jansen; Antonios G Mikos; Michael A Barry
Journal:  Biomaterials       Date:  2004-12       Impact factor: 12.479

5.  Expanded anticancer therapeutic window of hexon-modified oncolytic adenovirus.

Authors:  Elena V Shashkova; Shannon M May; Konstantin Doronin; Michael A Barry
Journal:  Mol Ther       Date:  2009-09-15       Impact factor: 11.454

6.  Macrophage depletion combined with anticoagulant therapy increases therapeutic window of systemic treatment with oncolytic adenovirus.

Authors:  Elena V Shashkova; Konstantin Doronin; Julien S Senac; Michael A Barry
Journal:  Cancer Res       Date:  2008-07-15       Impact factor: 12.701

7.  Modification of adenoviral vectors with polyethylene glycol modulates in vivo tissue tropism and gene expression.

Authors:  Sean E Hofherr; Elena V Shashkova; Eric A Weaver; Reeti Khare; Michael A Barry
Journal:  Mol Ther       Date:  2008-05-06       Impact factor: 11.454

8.  Effects of shielding adenoviral vectors with polyethylene glycol on vector-specific and vaccine-mediated immune responses.

Authors:  Eric A Weaver; Michael A Barry
Journal:  Hum Gene Ther       Date:  2008-12       Impact factor: 5.695

9.  Chemical modification with high molecular weight polyethylene glycol reduces transduction of hepatocytes and increases efficacy of intravenously delivered oncolytic adenovirus.

Authors:  Konstantin Doronin; Elena V Shashkova; Shannon M May; Sean E Hofherr; Michael A Barry
Journal:  Hum Gene Ther       Date:  2009-09       Impact factor: 5.695

10.  Comparison of replication-competent, first generation, and helper-dependent adenoviral vaccines.

Authors:  Eric A Weaver; Pramod N Nehete; Stephanie S Buchl; Julien S Senac; Donna Palmer; Philip Ng; K Jagannadha Sastry; Michael A Barry
Journal:  PLoS One       Date:  2009-03-31       Impact factor: 3.240

View more
  4 in total

Review 1.  Development and application of reporter-expressing mononegaviruses: current challenges and perspectives.

Authors:  Darryl Falzarano; Allison Groseth; Thomas Hoenen
Journal:  Antiviral Res       Date:  2014-01-23       Impact factor: 5.970

2.  Bioluminescence imaging of Chlamydia muridarum ascending infection in mice.

Authors:  Jessica Campbell; Yumeng Huang; Yuanjun Liu; Robert Schenken; Bernard Arulanandam; Guangming Zhong
Journal:  PLoS One       Date:  2014-07-01       Impact factor: 3.240

Review 3.  Applications of Replicating-Competent Reporter-Expressing Viruses in Diagnostic and Molecular Virology.

Authors:  Yongfeng Li; Lian-Feng Li; Shaoxiong Yu; Xiao Wang; Lingkai Zhang; Jiahui Yu; Libao Xie; Weike Li; Razim Ali; Hua-Ji Qiu
Journal:  Viruses       Date:  2016-05-06       Impact factor: 5.048

Review 4.  The importance of imaging strategies for pre-clinical and clinical in vivo distribution of oncolytic viruses.

Authors:  Adrian Pelin; Jiahu Wang; John Bell; Fabrice Le Boeuf
Journal:  Oncolytic Virother       Date:  2018-03-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.